TRPC6 Inhibitor BI 764198 in Focal Segmental Glomerulosclerosis: Phase 2 Study Design

Kidney Int Rep. 2023 Sep 29;8(12):2822-2825. doi: 10.1016/j.ekir.2023.09.026. eCollection 2023 Dec.
No abstract available

Keywords: TRPC6 cation channel; focal segmental glomerulosclerosis; phase 2 clinical trial; podocytes; proteinuria; research design.